A new control signal from moving muscle
Researchers at MIT and collaborating hospitals have reported a wireless magnetic implant system that tracks the mechanics of residual muscles in people with below-knee amputations. The study, published in Nature Sensors on 29 October 2026, is important because powered prostheses need reliable information about what the user intends a joint to do. Conventional surface electromyography measures electrical activation through the skin, but sweat, signal cross-talk and the fading of electrical activity during sustained contraction can make that signal an imperfect proxy for muscle length, velocity and force.
The new approach, known as magnetomicrometry, uses pairs of permanent magnetic beads implanted in residual-limb muscles. A skin-mounted magnetometer array tracks the beads wirelessly and calculates how the muscle contracts or stretches. The reported platform can track 3 millimetre beads at depths of up to 6 centimetres with sub-millimetre resolution.
What the human study actually showed
The researchers tested the system in three participants with transtibial amputations. Each had an agonist-antagonist myoneural interface, a surgical reconstruction that reconnects opposing muscle pairs so they continue to move in a coordinated way and provide proprioceptive information after amputation. Magnets were implanted in as many as four muscles associated with the ankle joint.
The same muscles also carried implanted electrodes, allowing the team to compare magnetic tracking with implanted electromyography and conventional surface electromyography. Across most evaluated outcomes, the magnetic system matched or outperformed the electrical methods for estimating muscle state and producing accurate, responsive control signals.
There is an important limitation. The participants were not walking with a magnetically controlled prosthetic leg. They used their residual muscles to move a cursor on a screen, with the cursor representing degrees of freedom that could later control a robotic ankle-foot prosthesis. The result therefore demonstrates human feasibility and a promising control interface, not a completed clinical system or improved real-world mobility.
Why it could matter
A powered limb controller must translate intention into joint position, torque and impedance. Direct measurement of muscle mechanics could give that controller a more stable and mechanically relevant input than electrical activation alone. If the result holds in larger trials during walking, the system could make powered limbs more intuitive and reduce the need for users to adapt their movement to unreliable control signals.
The evidence remains preliminary. The sample consisted of only three people, all with specialised surgical anatomy. The study does not yet establish long-term clinical benefit, comparative walking safety, implant durability, infection risk, cost, reimbursement or applicability to people with conventional amputations. A larger study using the system to control prosthetic limbs is under way.
Commercial availability is moving on a separate track
In a separate development, Bristol-based Open Bionics is now offering its Hero FLEX system for above-elbow limb differences. The modular system can switch between a bionic hand and more than 50 activity attachments. A former British paratrooper was reported in early November as the first person in the UK fitted with the above-elbow configuration.
The system uses a hollow, 3D-printed socket intended to improve ventilation and allow sweat to drain during active use. That design may matter for users whose work, sport or daily activity makes conventional sockets uncomfortable. However, this first fitting is an access milestone rather than a controlled clinical comparison. Publicly available evidence located for this review does not establish that the design reduces infection, improves endurance or produces ordinary-human-equivalent dexterity. Funding and eligibility for above-elbow users also need to be confirmed case by case.
Current assessment
The magnetic sensing study is the more consequential scientific development because it tests a plausible route from residual muscle mechanics to stable, multi-degree-of-freedom control in humans. Its significance lies in what it may enable after larger walking trials, not in present performance. The Hero FLEX expansion is more immediately available and could improve practical access for above-elbow users, but independent outcome data are still needed.
Neither development shows that prostheses now broadly match or exceed ordinary human capability. The strongest conclusion is narrower: human testing has improved the evidence for a potentially better control interface, while commercial modularity is expanding for a group that has historically faced greater weight, joint and socket challenges.